GlassScriptPhysician profile
Nitin K Ahuja
NPI 1396035689
$10,258.12
in general payments reported to CMS, 2019-2025
9 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.46 · 2021: $4,463 · 2023: $5,408 · 2024: $169 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,375 · Consulting Fee: $1,875 · Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,375.00 |
| Consulting Fee | $1,875.00 |
| Food and Beverage | $516.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $5,590.40 | 2023-2025 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $2,006.25 | 2021 | |
| Medtronic, INC. | $1,332.00 | 2021 | |
| Gi Supply, INC. | $1,125.00 | 2021 | |
| Anx Robotica Corp | $126.00 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.01 | 2025 | Xifaxan |
| Covidien LP | $28.46 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitin Ahuja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.